Botanical Dietary Supplements: Health Effects and Mechanisms of Action Minisymposium
Experimental Biology 2002
New Orleans, LA - April 20-24, 2002
Chaired by: Christine A. Swanson, Office of Dietary Supplements, NIH
Barbara Timmermann, University of Arizona, Tucson
Monday, April 22, 2002 8:00 am - 10:00 am
Room 345, Morial Convention Center
Christine Swanson
Overview: NIH-Supported Research of Botanical Dietary Supplements
Uwe Koetter, GlaxoSmithKline Consumer Healthcare, Parsippany, New Jersey
Quantitative EEG as an Objective Tool for Investigating the CNS Activity of a Valerian-Hops Preparation (Alluna)
Mohiuddin M. Taher, Heinrich-Heine University Duesseldorf, Germany
Curcumin Inhibits Ulraviolet Light Induced Human Immunodeficiency Virus Gene Expression
D. James Morre, Purdue University, West Lafayette, Indiana
tNOX, Molecular Target for the Anticancer Activity of Tea Catechins and Polyphenol Synergies
Jin-Rong Zhou, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Tea Polyphenols Potentiate Anti-Prostate Cancer Activity of the Herbal Supplement PC-SPES
Kishore Gadde, MD, Duke University Medical Center
Results of Hypericum perforatum (St. John’s wort) Trial in Depression
|
|
